Back

Cardiovascular disease burden attributable to decreased estimated glomerular filtration rate: insights from the ATTICA study (2002-2022)

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic diseases (1) Epidemiology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Evangelia Damigou

Harokopio University, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Comparison of nutritional risk scores for predicting cardiovascular morbidity and mortality in incident haemodialysis patients
Assistant Professor H. Takahashi (Toyoake, JP)
Abstract Slides Video
Presentation thumbnail
Impact of cardiometabolic index on cardiovascular-kidney-metabolic syndrome stage progression: a nationwide prospective cohort study
Miss S. Wu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of body mass index and prediabetes on the risk of type 2 diabetes and cardiovascular events following a recent myocardial infarction
Doctor P. Tonnesen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Associations of metabolic vulnerability index with cardiometabolic diseases, multimorbidity, and all-cause mortality
Doctor S. Zhu (Hangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Blood pressure, glycemic, and cholesterol control among adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2023
Doctor J. Gong (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiometabolic diseases (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Incidence of major cardiovascular outcomes in patients with chronic kidney disease by severity: a United States population-based study using electronic medical records
thumbnail
Congress Presentation
Exploring the hemoglobin-cardiovascular link in chronic kidney disease patients
thumbnail
Congress Presentation
Synergistic adverse impact of diabetes and chronic kidney disease on cardiovascular mortality in patients underwent percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources